Result of general meetings

Dublin, ireland, and boston ma, july 28, 2021, amryt (nasdaq: amyt, aim: amyt), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, is pleased to announce that all resolutions presented to shareholders at both of today's general meetings were duly passed.
AMYT Ratings Summary
AMYT Quant Ranking